Hernández-Marín I, Aragón-López Cl, Aldama-González PL, Jiménez-Huerta J

Language: Spanish
References: 15
Page: 14-18
PDF size: 1884.72 Kb.

ABSTRACT

Objective: To determine the prevalence of Chlamydia, Ureaplasma and Mycoplasma in patients with peritoneal tubal factor infertility and altered.
Material and Method: A descriptive, observational, retrospective, transversal, infertility patients Juarez Hospital of Mexico 2013 to 2015. Study included patients with infertility diagnosis and detection of antibodies (IgG) by ELISA for Chlamydia and vaginal cultures for Mycoplasma and Ureaplasma, hysterosalpingography and histerolaparoscopia with chromotubation
Results: 46 patients with a mean age of 32.5 years. It was found that 36% were positive for these infections (n = 17): Chlamydia in 8.7% (n = 4), Ureaplasma in 21.7% (n = 10) and Mycoplasma in 6.5% (n = 3). Chlamydia patients and bilateral tubal occlusion (OTB) in 5.8% (n = 1), Ureaplasma and OTB (n = 5) were identified in 29.4% of them with pelvic inflammatory disease (PID) and tubal obstruction Ureaplasma right (OTD) in 5.8% (n = 1), Ureaplasma and tubal patency but with loose adhesions in 5.8% (n = 1) and Mycoplasma with OTB in 11.1% (n = 2), p = 0.425. Hysterosalpingography showed a sensitivity of 59% and specificity of 79%.
Conclusions:Although there was no association of variables, Ureaplasma infection was more common in patients with infertility and tubal damage.

REFERENCES

1. Practice Committee ASMR. Definition of infertility and recurrent pregnancy loss. Fertil SteriI 2008;89:1603.

2. Practice Committee ASRM. Committee Opinion: role of tubal surgery in the era of assisted reproductive technology. Fertility Steril 2012; 97:539

3. Speroff L, Fritz M. Esterilidad femenina. En: Speroff L, Fritz M, editores. Endocrinología ginecológica clínica y esterilidad. 8ª ed. España: Lippincott Williams, 2012:1049- 1067.

4. The Practice Committee of the American Society for Reproductive Medicine. Optimal evaluation of the infertile women. Fertil Steril 2006;86:S264-S267.

5. Mardh PA. Tubal factor infertility, with special regard to chlamydial salpingitis. Current Opin Infect Dis 2004; 17:49–52

6. Jaczek KH. Genital Chlamydia trachomatis: detection, treatment, and patient education. Can Fam Phys 1985; 31:1861–1865

7. Thejils H, Rahm VA, Rosen G, Gnarpe H. Correlation between Chlamydia infection and clinical evaluation, vaginal wet smear, and cervical swab test in female adolescents. Am J Obstet Gynecol 1987; 157:974–976

8. Marais NF, Wessels PH, Smith MS, et. Al. Chlamydia trachomatis, Mycoplasma hominis and Ureaplasma urealyticum infections in women. Prevalence, risks and management at a South African infertility clinic. J Reprod Med 1991; 36:161–164

9. Clegg A, Passey M, Yoannes M, et. Al. High rates of genital mycoplasma infection in the highlands of Papua New Guinea determined both by culture and by a commercial detection kit. J Clin Microbiol 1997; 35:197–200

10. Papaioannou S, Afnan M, Jafettas J. Tubal assessment test: still have not found what we are looking for. Reprod Biomed Online 2007;15:376-382.

11. The ESHRE Capri workshop group. Optimal use of infertility diagnostic test and treatments. Hum Reprod 2000;15:723- 732.

12. Robertson JA, Stemke GW, Davis JW, R. Et al. Proposal of Ureaplasma parvum sp. Nov. And emended description of Ureaplasma urealyticum. Int J Syst Evol Microbiol 2002; 52:587–597

13. Mallard K, Schopfer K, Bodmer T. Development of realtime PCR for the differential detection and quantification of Ureaplasma urealyticum and Ureaplasma parvum. J Microbiol Methods 2005; 60:13–19.

14. Anthony N. Imudia, et al. The prevalence of ureaplasma urealyticum, mycoplasma hominis, chlamydia trachomatis and neisseria gonorrhoeae infections, and the rubella status of patients undergoing an initial infertility evaluation. J Assist Reprod Genet 2008; 25:43–46.

15. Melih A. Guven, et al. Prevalance of Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis infections in the unexplained infertile women. Arch Gynecol Obstet 2007; 276:219–223.